Weight-Loss Interventions Linked to Significant Psoriasis Symptom Improvement

Weight-Loss Interventions Linked to Significant Psoriasis Symptom Improvement

The Connection Between Metabolic Health and Skin Clarity Recent clinical evidence published in the European Medical Journal (EMJ) confirms that structured weight-loss interventions significantly reduce the severity of psoriasis symptoms in patients living with obesity. Researchers identified a clear correlation between metabolic improvement and reduced systemic inflammation, marking a potential shift in how dermatologists approach…

Read More
Dual-Action Therapy: Exploring the Efficacy of Tirzepatide and Ixekizumab in Psoriasis Management

Dual-Action Therapy: Exploring the Efficacy of Tirzepatide and Ixekizumab in Psoriasis Management

A recent clinical study has unveiled promising results for patients suffering from plaque psoriasis, demonstrating that a combination therapy of the GLP-1 receptor agonist tirzepatide and the IL-17A inhibitor ixekizumab can effectively target both dermatological symptoms and systemic metabolic health. The trial, which concluded in 2024, highlights a transformative shift in how clinicians approach the…

Read More